Cite
Pathological Nodal and Vascular Involvement Significantly Impacts the Recurrence Risk in Different Time Frames in Patients With Resectable and Borderline Resectable Pancreatic Cancer: Long-term Conditional Recurrence-free Survival Analysis in the Setting of a Neoadjuvant Treatment Strategy.
MLA
Takahashi, Hidenori, et al. “Pathological Nodal and Vascular Involvement Significantly Impacts the Recurrence Risk in Different Time Frames in Patients With Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Conditional Recurrence-Free Survival Analysis in the Setting of a Neoadjuvant Treatment Strategy.” Annals of Surgery, vol. 278, no. 6, Dec. 2023, pp. e1216–23. EBSCOhost, https://doi.org/10.1097/SLA.0000000000005879.
APA
Takahashi, H., Akita, H., Wada, H., Miyata, H., Eguchi, H., Ohigashi, H., Sakon, M., & Ishikawa, O. (2023). Pathological Nodal and Vascular Involvement Significantly Impacts the Recurrence Risk in Different Time Frames in Patients With Resectable and Borderline Resectable Pancreatic Cancer: Long-term Conditional Recurrence-free Survival Analysis in the Setting of a Neoadjuvant Treatment Strategy. Annals of Surgery, 278(6), e1216–e1223. https://doi.org/10.1097/SLA.0000000000005879
Chicago
Takahashi, Hidenori, Hirofumi Akita, Hiroshi Wada, Hiroshi Miyata, Hidetoshi Eguchi, Hiroaki Ohigashi, Masato Sakon, and Osamu Ishikawa. 2023. “Pathological Nodal and Vascular Involvement Significantly Impacts the Recurrence Risk in Different Time Frames in Patients With Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Conditional Recurrence-Free Survival Analysis in the Setting of a Neoadjuvant Treatment Strategy.” Annals of Surgery 278 (6): e1216–23. doi:10.1097/SLA.0000000000005879.